MOLOGEN AG

mologen-ag-logo

MOLOGEN, founded in 1998, is headquartered in Berlin and employs around 50 people. Prof. Burghardt Wittig is the founder of the Company.MOLOGEN is an internationally operating biopharmaceutical company, specializing in research and clinical development of innovative drugs in the fields of cancer and infectious diseases.

#SimilarOrganizations #Website #More

MOLOGEN AG

Industry:
Biopharma Pharmaceutical

Founded:
1998-01-01

Address:
Berlin, Berlin, Germany

Country:
Germany

Website Url:
http://www.mologen.com

Total Employee:
11+

Status:
Active

Contact:
+49-30-84 17 88 -0

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Sectigo SSL Sectigo Domain SSL Amazon Elastic Load Balancing Sticky Session 1and1 Amazon ALB


Similar Organizations

bioscientia-institute-of-medical-diagnostics-logo

Bioscientia Institute of Medical Diagnostics

Bioscientia is an internationally operating service company

not_available_image

Oxford Asymmetry International

Oxford Asymmetry International operates as an outsourcing arm for pharmaceutical companies.

takeda-oncology-logo

Takeda Oncology

Takeda Oncology is a leading biopharmaceutical company.

Stock Details


Company's stock symbol is ETR:MGNK

Official Site Inspections

http://www.mologen.com Semrush global rank: 9.1 M Semrush visits lastest month: 213

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Mologen AG"

Mologen AG - Crunchbase Company Profile & Funding

Jul 26, 2019 · Mologen AG is an internationally operating bio pharmaceutical company. MOLOGEN, founded in 1998, is headquartered in Berlin and employs around 50 people. Prof.See details»

Startseite

MOLOGEN ist ein biopharmazeutisches Unternehmen, das sich auf die Forschung und klinische Entwicklung innovativer medizinischer Therapien spezialisiert hat. Unser ehemals an der Frankfurter Wertpapierbörse notiertes …See details»

MOLOGEN AG - LinkedIn

MOLOGEN is a biopharmaceutical company specializing in the research and clinical development of innovative medical therapies. Our company, formerly listed on the Frankfurt Stock …See details»

Mologen AG - Berlin, Germany - bionity.com

MOLOGEN AG is a biopharmaceutical company located in Berlin, Germany and specializes in the development of novel DNA-based medicines against cancer and vaccines against infectious …See details»

Mologen AG Company Profile | Hamburg, Hamburg, Germany

Find company research, competitor information, contact details & financial data for Mologen AG of Hamburg, Hamburg. Get the latest business insights from Dun & Bradstreet.See details»

MOLOGEN AG - Company Profile - pharmaservicesdirectory.com

MOLOGEN AG is a biotechnology company specializing in the clinical development of innovative drugs in the fields of oncology and infectious diseases. The cancer immunotherapy lefitolimod …See details»

MOLOGEN Company Profile - Office Locations, Competitors ... - Craft

Nov 24, 2020 · MOLOGEN has 4 employees at their 1 location and €81 k in annual revenue in FY 2019. See insights on MOLOGEN including office locations, competitors, revenue, financials, …See details»

Mologen (Group) - Life-Sciences-Europe.com

Jan 1, 1997 · MOLOGEN AG, a German biopharmaceutical company with headquarters in Berlin specializes in the research and development of innovative medications on the basis of DNA …See details»

Mologen AG: Governance, Directors and Executives & Committees ...

Mologen AG is a Germany-based company engaged in the biotechnology and medical research industry. The Company specializes in the research and development of drugs in the fields of …See details»

Mologen Company Profile 2024: Stock Performance & Earnings

Mologen AG is a Germany based biotechnology company. It is principally engaged in the research, development, and marketing of products in the area of molecular medicine. The …See details»

Mologen AG - Funding, Financials, Valuation & Investors

Nov 19, 1998 · Mologen AG is an internationally operating bio pharmaceutical company.See details»

Mologen AG - Life-Sciences-Europe.com

MOLOGEN AG, a German biopharmaceutical company with headquarters in Berlin specializes in the research and development of innovative medications on the basis of DNA structures.See details»

Mologen AG | VentureRadar

MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases. VentureRadar Research / …See details»

Mologen – Wikipedia

Die MOLOGEN AG war ein in der Biotechnologie und Biopharmazie international tätiges Unternehmen, das sich auf die Erforschung und klinische Entwicklung innovativer Wirkstoffe in …See details»

The German CEO Pushing for an Immunotherapy to Treat Cancer …

Oct 23, 2017 · Mariola Söhngen, CEO of Mologen, discusses biotech entrepreneurship in Germany and her company's unique immunotherapy against both cancer and HIV.See details»

MOLOGEN AG Announces Top Line Data of Pivotal IMPALA Study …

Aug 5, 2019 · MOLOGEN AG is a German biopharmaceutical Company and a pioneer in the field of immunotherapy on account of its unique active agents and technologies. Alongside a focus …See details»

Mologen AG - Crunchbase

Companies like Mologen AG include LimmaTech Biologics, Jenrin Discovery, and Bioscientia Institute of Medical Diagnostics. Jenrin Discovery Philadelphia , Pennsylvania , United States …See details»

Mologen — Global lefitolimod partnership close to completion

Sep 21, 2018 · Mologen announced that it has signed term sheets for a global partnership with Oncologie for its lead asset, lefitolimod. The deal is expected to complete in Q119, and in the …See details»

Mologen Files for Insolvency after Cancer Immunotherapy Phase …

Dec 6, 2019 · A DNA immunotherapy drug developed by the German company Mologen has failed to improve the survival of patients with colorectal cancer in a phase III trial.See details»

Mologen AG - VentureRadar

MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases. VentureRadar Research / …See details»

linkstock.net © 2022. All rights reserved